- Valuation
- ₹31,680 Cr

About Global Health Limited
Data last updated:
Global Health Limited is a public limited company based in New Delhi, Delhi, India. It operates in the hospital and clinical services segment of the healthcare sector. It was incorporated on 13 August 2004 and has been in existence for over 22 years.
Global Health is part of the Nifty 500 and BSE 500 indices. Its director Ravi Jaipuria and family are #25 among India's richest people (2026). Its director Rajan Bharti Mittal and family are #42 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN L85110DL2004PLC128319. Its GSTIN is 07AACCG2681C2ZW (Delhi). The company holds 11 GST registrations, of which 8 are active. It is a listed company as per MCA records. Its shares are listed on BSE: 543654 and NSE: MEDANTA.
The company has an authorised share capital of ₹233.52 Cr and a paid-up capital of ₹53.77 Cr. It was formerly known as Global Health Private Limited. It is led by directors including Naresh Trehan (Managing Director) and Pankaj Prakash Sahni (Whole-Time Director).
Its last annual general meeting (AGM) was held on 19 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Medanta – Mediclinic E – 18 Defence Colony, New Delhi, Delhi, India – 110024.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹4,410.27 Cr, a growth of 19.4% compared to the previous year. For the same year it recorded a net profit of ₹557.19 Cr (net margin 12.6%) and EBITDA of ₹909.42 Cr (EBITDA margin 20.6%). The net worth stands at ₹3,961.57 Cr (up 17% YoY). Total assets are valued at ₹5,340.86 Cr (up 25.9% YoY).
The company has about 10,344 employees on its provident fund (EPFO) records. Its group structure includes 3 subsidiaries.
The company is associated with 6 brands, including Lifecard, HotHealth, PrimaryClinic, ReferralNet, Global Health and others. As per MCA filings, the company has open charges of ₹890 Cr and satisfied charges of ₹996.42 Cr on record. Court records list 66 cases involving the company, including 14 filed by the company and 53 filed against it; 16 cases are pending. The company has 19 deals on record (7 funding rounds, 5 market trades, 5 secondary share transfers), with disclosed funding of ₹462.32 Cr; the latest was in June 2026. The company has 39 MSME Form 1 returns on record between 2013 and 2024, listing 34,957 overdue payments to 652 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medanta.org.
Company details
CIN history
Global Health has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L85110DL2004PLC128319, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L85110DL2004PLC128319 | Current |
| U85110DL2004PLC128319 | Previous |
| U85110DL2004PTC128319 | Previous |
Recognitions & Rankings of Global Health
- #25 Ravi Jaipuria & family ₹97,300 Cr
- #42 Rajan Bharti Mittal & family ₹60,700 Cr
- #252 Hari Bhartia ₹14,600 Cr
Contact details
Global Health Limited's registered office is in New Delhi, Delhi. Its website is medanta.org. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressMedanta – Mediclinic E – 18 Defence Colony, New Delhi, Delhi, India – 110024
- IndustryHealthcare, Hospitals
To see the full contact details of Global Health Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Global Health operates multiple associated brands including Lifecard, HotHealth, and PrimaryClinic. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| App for managing personal health records and tracking medical progress. | lifecard.com | |
| Offers digital platform for healthcare with online bookings, telehealth, and patient forms. | hothealth.com | |
| Medical software for efficient practice management and patient care. | primaryclinic.com.au | |
| Secure platform for exchanging patient information among healthcare providers. | referralnet.com.au | |
| Software applications for Australia's healthcare sector are developed. | global-health.com | |
| Chain of multi-super specialty healthcare hospitals | medanta.org |
Business activity
The main business activity of Global Health is hospital and medical care. In detail, this covers hospital activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q1 | Hospital activities |
To see the full business activity and turnover split of Global Health Limited, buy the company report.
Financials of Global Health Limited
FY 2025-26 filings availableGlobal Health Limited reported revenue of ₹4,410.27 Cr (up 19.4% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 4,410 | 3,692 | 3,275 | 2,710 | 2,167 | 1,447 | 1,500 |
| Revenue growth | +19.4% | +12.7% | +20.9% | +25.0% | +49.8% | -3.6% | - |
| EBITDA | 909 | 836 | 809 | 636 | 458 | 197 | 192 |
| EBITDA margin | +20.6% | +22.7% | +24.7% | +23.5% | +21.1% | +13.6% | +12.8% |
| Profit before tax | 715 | 647 | 627 | 449 | 281 | 32.48 | 63.87 |
| Net profit | 557 | 518 | 478 | 327 | 196 | 28.93 | 36.35 |
| Net profit margin | +12.6% | +14.0% | +14.6% | +12.1% | +9.0% | +2.0% | +2.4% |
| EPS (₹) | 20.71 | 17.92 | 17.81 | 12.16 | 7.75 | 5.81 | 7.36 |
| Balance sheet | |||||||
| Total assets | 5,341 | 4,242 | 3,834 | 3,664 | 2,832 | 2,392 | 2,354 |
| Net worth | 3,962 | 3,386 | 2,906 | 2,428 | 1,616 | 1,382 | 1,350 |
| Total debt | 1,190 | 718 | 802 | 1,122 | 1,109 | 931 | 929 |
| Cash & bank | 1,130 | 1,122 | 1,175 | 1,278 | 512 | 289 | 250 |
| Net working capital | 1,111 | 1,009 | 1,063 | 1,146 | 498 | 200 | 174 |
| Cash flow | |||||||
| Cash from operations | 714 | 624 | 612 | 645 | 311 | 242 | 175 |
| Cash from investing | (1,089) | (721) | (441) | (342) | (421) | (239) | (87.07) |
| Cash from financing | 272 | (97.23) | (514) | 346 | 160 | (80.72) | (0.88) |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,469 | 1,304 | 1,159 | 1,121 | 1,099 | 1,031 | 931 | 943 |
| Revenue growth (YoY) | +33.6% | +26.5% | +24.5% | +18.8% | +14.9% | +19.7% | - | - |
| Other income | 23.62 | 22.16 | 36.74 | 21.74 | 35.71 | 20.46 | 22.93 | 16.02 |
| EBITDA | 370 | 287 | 244 | 181 | 231 | 247 | 175 | 238 |
| EBITDA margin | +25.2% | +22.0% | +21.0% | +16.1% | +21.0% | +23.9% | +18.8% | +25.2% |
| Depreciation | 70.80 | 68.98 | 66.52 | 61.19 | 49.73 | 45.11 | 49.25 | 48.45 |
| Interest | 28.09 | 26.68 | 26.71 | 21.51 | 17.11 | 13.79 | 15.03 | 16.28 |
| Profit before tax | 295 | 213 | 187 | 120 | 200 | 208 | 133 | 189 |
| Tax | 75.68 | 56.02 | 45.63 | 24.75 | 41.41 | 49.16 | 32.06 | 46.21 |
| Net profit | 219 | 157 | 142 | 95.03 | 158 | 159 | 101 | 143 |
| EPS (₹) | 8.20 | 5.90 | 5.35 | 3.54 | 5.89 | 5.91 | 3.77 | 5.32 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 3,709 | 3,204 | 2,975 | 1,974 | 1,765 | 1,227 | 1,472 |
| Revenue growth | +15.8% | +7.7% | +50.7% | +11.8% | +43.8% | -16.6% | - |
| EBITDA | 744 | 723 | 753 | 422 | 381 | 173 | 218 |
| EBITDA margin | +20.1% | +22.6% | +25.3% | +21.4% | +21.6% | +14.1% | +14.8% |
| Profit before tax | 650 | 623 | 659 | 352 | 296 | 84.43 | 131 |
| Net profit | 496 | 498 | 486 | 264 | 219 | 56.70 | 103 |
| Net profit margin | +13.4% | +15.6% | +16.3% | +13.4% | +12.4% | +4.6% | +7.0% |
| EPS (₹) | 18.47 | 17.18 | 18.11 | 9.82 | 8.64 | 11.55 | 20.82 |
| Balance sheet | |||||||
| Total assets | 4,849 | 3,967 | 3,584 | 2,853 | 2,123 | 1,770 | 1,690 |
| Net worth | 4,013 | 3,498 | 3,037 | 2,489 | 1,740 | 1,484 | 1,423 |
| Total debt | 683 | 337 | 424 | 288 | 308 | 228 | 18.52 |
| Cash & bank | 1,076 | 1,053 | 1,137 | 1,145 | 441 | 255 | 219 |
| Net working capital | 1,068 | 979 | 1,060 | 1,073 | 478 | 223 | 176 |
| Cash flow | |||||||
| Cash from operations | 573 | 528 | 559 | 431 | 235 | 201 | 193 |
| Cash from investing | (931) | (638) | (519) | (257) | (313) | (250) | (45.34) |
| Cash from financing | 264 | (94.49) | (379) | 404 | 97.59 | (36.67) | (55.64) |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,208 | 1,079 | 961 | 940 | 926 | 882 | 803 | 812 |
| Revenue growth (YoY) | +30.4% | +22.3% | +19.7% | +15.7% | +39.4% | +44.3% | - | - |
| Other income | 25.89 | 24.06 | 35.81 | 24.66 | 38.79 | 42.73 | 25.67 | 19.47 |
| Total expenses | 918 | 849 | 767 | 801 | 734 | 688 | 658 | 611 |
| EBITDA | 290 | 230 | 193 | 139 | 193 | 195 | 145 | 202 |
| EBITDA margin | +24.0% | +21.3% | +20.1% | +14.8% | +20.8% | +22.1% | +18.1% | +24.8% |
| Depreciation | 56.15 | 54.60 | 52.21 | 47.86 | 37.43 | 33.41 | 37.98 | 37.35 |
| Interest | 17.07 | 15.89 | 13.46 | 13.08 | 8.88 | 5.66 | 7.10 | 8.46 |
| Profit before tax | 243 | 183 | 163 | 103 | 185 | 198 | 126 | 175 |
| Tax | 61.81 | 45.81 | 39.35 | 22.98 | 44.85 | 46.29 | 32.48 | 43.89 |
Financial Statements
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,469 | 1,304 | 1,159 | 1,121 | 1,099 | 1,031 | 931 | 943 |
| Revenue growth (YoY) | +33.6% | +26.5% | +24.5% | +18.8% | +14.9% | +19.7% | - | - |
| Other income | 23.62 | 22.16 | 36.74 | 21.74 | 35.71 | 20.46 | 22.93 | 16.02 |
| EBITDA | 370 | 287 | 244 | 181 | 231 | 247 | 175 | 238 |
| EBITDA margin | +25.2% | +22.0% | +21.0% | +16.1% | +21.0% | +23.9% | +18.8% | +25.2% |
| Depreciation | 70.80 | 68.98 | 66.52 | 61.19 | 49.73 | 45.11 | 49.25 | 48.45 |
| Interest | 28.09 | 26.68 | 26.71 | 21.51 | 17.11 | 13.79 | 15.03 | 16.28 |
| Profit before tax | 295 | 213 | 187 | 120 | 200 | 208 | 133 | 189 |
| Tax | 75.68 | 56.02 | 45.63 | 24.75 | 41.41 | 49.16 | 32.06 | 46.21 |
| Net profit | 219 | 157 | 142 | 95.03 | 158 | 159 | 101 | 143 |
| EPS (₹) | 8.20 | 5.90 | 5.35 | 3.54 | 5.89 | 5.91 | 3.77 | 5.32 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 4,410 | 3,692 | 3,275 | 2,710 | 2,167 | 1,447 | 1,500 |
| Revenue growth | +19.4% | +12.7% | +20.9% | +25.0% | +49.8% | -3.6% | - |
| Other income | 118 | 78.95 | 74.66 | 49.29 | 38.52 | 31.42 | 43.85 |
| Total expenses | 3,501 | 2,856 | 2,466 | 2,074 | 1,709 | 1,250 | 1,309 |
| Employee cost | 1,096 | 825 | 735 | 636 | 568 | 466 | 539 |
| EBITDA | 909 | 836 | 809 | 636 | 458 | 197 | 192 |
| EBITDA margin | +20.6% | +22.7% | +24.7% | +23.5% | +21.1% | +13.6% | +12.8% |
| Depreciation | 223 | 194 | 173 | 150 | 130 | 123 | 115 |
| Interest | 90.05 | 74.35 | 83.78 | 86.33 | 86.32 | 72.64 | 56.56 |
| Profit before tax | 715 | 647 | 627 | 449 | 281 | 32.48 | 63.87 |
| Tax | 161 | 166 | 149 | 123 | 84.36 | 3.66 | 27.54 |
| Net profit | 557 | 518 | 478 | 327 | 196 | 28.93 | 36.35 |
| Net profit margin | +12.6% | +14.0% | +14.6% | +12.1% | +9.0% | +2.0% | +2.4% |
| EPS (₹) | 20.71 | 17.92 | 17.81 | 12.16 | 7.75 | 5.81 | 7.36 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 53.74 | 53.72 | 53.70 | 53.64 | 50.64 | 49.59 | 49.35 |
| Reserves & surplus | 3,908 | 3,333 | 2,852 | 2,375 | 1,565 | 1,300 | 1,268 |
| Shareholders' funds (net worth) | 3,962 | 3,386 | 2,906 | 2,428 | 1,616 | 1,382 | 1,350 |
| Minority interest | 22.71 | 1.10 | (0.03) | 0.00 | 0.00 | 0.00 | 0.00 |
| Secured loans | 631 | 276 | 310 | 754 | 783 | 568 | 552 |
| Unsecured loans | 559 | 442 | 492 | 368 | 326 | 363 | 377 |
| Total debt | 1,190 | 718 | 802 | 1,122 | 1,109 | 931 | 929 |
| Total liabilities | 5,341 | 4,242 | 3,834 | 3,664 | 2,832 | 2,392 | 2,354 |
| Assets | |||||||
| Gross block | 5,047 | 3,578 | 3,146 | 2,877 | 2,458 | 2,173 | 2,141 |
| Net block | 3,795 | 2,514 | 2,236 | 2,050 | 1,776 | 1,616 | 1,703 |
| Capital work in progress | 132 | 533 | 388 | 327 | 439 | 464 | 382 |
| Investments | 2.55 | 2.71 | 0.05 | 0.05 | 0.05 | 0.05 | 0.00 |
| Inventories | 78.98 | 67.14 | 66.85 | 60.37 | 53.39 | 39.76 | 38.52 |
| Sundry debtors | 411 | 292 | 215 | 194 | 180 | 134 | 149 |
| Cash & bank balances | 1,130 | 1,122 | 1,175 | 1,278 | 512 | 289 | 250 |
| Loans & advances | 54.53 | 51.79 | 51.29 | 46.81 | 66.33 | 39.44 | 40.81 |
| Total current assets | 1,675 | 1,533 | 1,509 | 1,579 | 812 | 502 | 479 |
| Total current liabilities | 564 | 525 | 446 | 433 | 314 | 302 | 305 |
| Net working capital | 1,111 | 1,009 | 1,063 | 1,146 | 498 | 200 | 174 |
| Total assets | 5,341 | 4,242 | 3,834 | 3,664 | 2,832 | 2,392 | 2,354 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 230 | 425 | 767 | 119 | 69.47 | 148 | 60.45 |
| Net cash from operating activities | 714 | 624 | 612 | 645 | 311 | 242 | 175 |
| Net cash from investing activities | (1,089) | (721) | (441) | (342) | (421) | (239) | (87.07) |
| Net cash from financing activities | 272 | (97.23) | (514) | 346 | 160 | (80.72) | (0.88) |
| Net change in cash | (103) | (194) | (343) | 648 | 49.97 | (78.11) | 87.12 |
| Closing cash | 1,130 | 1,122 | 1,175 | 1,278 | 512 | 289 | 250 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +19.4% | +12.7% | +20.9% | +25.0% | +49.8% | -3.6% | - |
| EBITDA growth | +8.7% | +3.4% | +27.1% | +38.9% | +132.6% | +2.8% | - |
| PBT growth | +10.5% | +3.2% | +39.6% | +60.1% | +763.8% | -49.2% | -23.3% |
| Net income growth | +7.5% | +8.6% | +46.2% | +66.6% | +577.5% | -20.4% | - |
| Revenue CAGR (3Y) | +17.6% | +19.4% | +31.3% | +21.8% | +14.2% | +2.5% | +2.8% |
| EBITDA CAGR (3Y) | +12.7% | +22.2% | +60.2% | +49.2% | +38.5% | +16.2% | -14.0% |
| Profitability & leverage | |||||||
| Net income margin | +12.6% | +13.0% | +14.6% | +12.0% | +9.1% | +2.0% | +2.4% |
| Return on capital employed | +16.8% | +17.9% | +19.0% | +16.5% | +14.1% | +4.4% | +5.4% |
| Return on net worth | +15.1% | +15.3% | +17.9% | +16.1% | +13.1% | +2.1% | +2.8% |
| Debt / equity | 0.26 | 0.24 | 0.36 | 0.55 | 0.68 | 0.68 | 0.65 |
| Long-term debt / equity | 0.24 | 0.20 | 0.30 | 0.49 | 0.61 | 0.64 | 0.61 |
| Interest cover | 13.11 | 11.57 | 13.17 | 17.75 | 26.29 | 98.56 | 73.86 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 1.02 | 1.10 | 1.09 | 1.02 | 0.94 | 0.67 | 0.82 |
| Inventory turnover | 60.37 | 55.11 | 51.49 | 47.64 | 46.53 | 36.96 | 48.55 |
| Debtors turnover | 12.55 | 14.56 | 16.00 | 14.48 | 13.81 | 10.23 | 9.58 |
| EPS (₹) | 20.71 | 17.92 | 17.81 | 12.16 | 7.75 | 5.81 | 7.36 |
| Dividend per share (₹) | 0.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 147.44 | 126.08 | 108.22 | 90.54 | 63.82 | 272.22 | 266.90 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,208 | 1,079 | 961 | 940 | 926 | 882 | 803 | 812 |
| Revenue growth (YoY) | +30.4% | +22.3% | +19.7% | +15.7% | +39.4% | +44.3% | - | - |
| Other income | 25.89 | 24.06 | 35.81 | 24.66 | 38.79 | 42.73 | 25.67 | 19.47 |
| Total expenses | 918 | 849 | 767 | 801 | 734 | 688 | 658 | 611 |
| EBITDA | 290 | 230 | 193 | 139 | 193 | 195 | 145 | 202 |
| EBITDA margin | +24.0% | +21.3% | +20.1% | +14.8% | +20.8% | +22.1% | +18.1% | +24.8% |
| Depreciation | 56.15 | 54.60 | 52.21 | 47.86 | 37.43 | 33.41 | 37.98 | 37.35 |
| Interest | 17.07 | 15.89 | 13.46 | 13.08 | 8.88 | 5.66 | 7.10 | 8.46 |
| Profit before tax | 243 | 183 | 163 | 103 | 185 | 198 | 126 | 175 |
| Tax | 61.81 | 45.81 | 39.35 | 22.98 | 44.85 | 46.29 | 32.48 | 43.89 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 3,709 | 3,204 | 2,975 | 1,974 | 1,765 | 1,227 | 1,472 |
| Revenue growth | +15.8% | +7.7% | +50.7% | +11.8% | +43.8% | -16.6% | - |
| Other income | 126 | 90.81 | 90.59 | 47.59 | 35.04 | 28.35 | 43.54 |
| Total expenses | 2,965 | 2,482 | 2,222 | 1,552 | 1,384 | 1,054 | 1,254 |
| Employee cost | 989 | 746 | 679 | 533 | 495 | 416 | 522 |
| EBITDA | 744 | 723 | 753 | 422 | 381 | 173 | 218 |
| EBITDA margin | +20.1% | +22.6% | +25.3% | +21.4% | +21.6% | +14.1% | +14.8% |
| Depreciation | 171 | 150 | 134 | 86.09 | 87.17 | 87.64 | 98.57 |
| Interest | 49.82 | 40.67 | 50.78 | 31.82 | 32.83 | 29.20 | 32.54 |
| Profit before tax | 650 | 623 | 659 | 352 | 296 | 84.43 | 131 |
| Tax | 153 | 162 | 172 | 88.46 | 77.04 | 27.14 | 28.18 |
| Net profit | 496 | 498 | 486 | 264 | 219 | 56.70 | 103 |
| Net profit margin | +13.4% | +15.6% | +16.3% | +13.4% | +12.4% | +4.6% | +7.0% |
| EPS (₹) | 18.47 | 17.18 | 18.11 | 9.82 | 8.64 | 11.55 | 20.82 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 53.74 | 53.72 | 53.70 | 53.64 | 50.64 | 49.59 | 81.85 |
| Reserves & surplus | 3,959 | 3,444 | 2,983 | 2,435 | 1,689 | 1,402 | 1,341 |
| Shareholders' funds (net worth) | 4,013 | 3,498 | 3,037 | 2,489 | 1,740 | 1,484 | 1,423 |
| Secured loans | 458 | 114 | 171 | 66.45 | 99.86 | 0.96 | 18.08 |
| Unsecured loans | 225 | 223 | 253 | 221 | 208 | 227 | 0.44 |
| Total debt | 683 | 337 | 424 | 288 | 308 | 228 | 18.52 |
| Total liabilities | 4,849 | 3,967 | 3,584 | 2,853 | 2,123 | 1,770 | 1,690 |
| Assets | |||||||
| Gross block | 4,009 | 2,823 | 2,491 | 1,472 | 1,410 | 1,354 | 1,350 |
| Net block | 2,903 | 1,861 | 1,645 | 810 | 827 | 851 | 929 |
| Capital work in progress | 120 | 458 | 280 | 74.94 | 6.42 | 4.16 | 3.47 |
| Investments | 389 | 366 | 362 | 765 | 734 | 626 | 500 |
| Inventories | 50.90 | 49.00 | 55.35 | 42.21 | 40.02 | 31.69 | 32.26 |
| Sundry debtors | 387 | 292 | 214 | 173 | 173 | 130 | 148 |
| Cash & bank balances | 1,076 | 1,053 | 1,137 | 1,145 | 441 | 255 | 219 |
| Loans & advances | 56.24 | 59.39 | 53.64 | 37.78 | 61.71 | 38.98 | 36.32 |
| Total current assets | 1,570 | 1,453 | 1,460 | 1,398 | 716 | 455 | 436 |
| Total current liabilities | 503 | 474 | 400 | 325 | 238 | 233 | 260 |
| Net working capital | 1,068 | 979 | 1,060 | 1,073 | 478 | 223 | 176 |
| Total assets | 4,849 | 3,967 | 3,584 | 2,853 | 2,123 | 1,770 | 1,690 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 190 | 395 | 734 | 65.31 | 45.31 | 132 | 39.98 |
| Net cash from operating activities | 573 | 528 | 559 | 431 | 235 | 201 | 193 |
| Net cash from investing activities | (931) | (638) | (519) | (257) | (313) | (250) | (45.34) |
| Net cash from financing activities | 264 | (94.49) | (379) | 404 | 97.59 | (36.67) | (55.64) |
| Net change in cash | (94.16) | (205) | (339) | 577 | 20.01 | (86.25) | 91.58 |
| Closing cash | 1,076 | 1,053 | 1,137 | 1,145 | 441 | 255 | 219 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +15.8% | +7.7% | +50.7% | +11.8% | +43.8% | -16.6% | - |
| EBITDA growth | +3.0% | -4.0% | +78.4% | +10.8% | +120.2% | -20.9% | - |
| PBT growth | +4.3% | -5.4% | +87.3% | +18.9% | +250.4% | -35.5% | +35.7% |
| Net income growth | -0.6% | +2.6% | +84.2% | +20.7% | +285.5% | -44.8% | - |
| Revenue CAGR (3Y) | +23.4% | +22.0% | +34.3% | +10.3% | +7.0% | -3.0% | +4.9% |
| EBITDA CAGR (3Y) | +20.8% | +23.8% | +63.3% | +24.5% | +38.4% | +10.0% | +22.6% |
| Profitability & leverage | |||||||
| Net income margin | +13.4% | +14.4% | +16.4% | +13.3% | +12.4% | +4.7% | +7.0% |
| Return on capital employed | +15.9% | +17.6% | +22.1% | +15.4% | +16.9% | +6.6% | +10.3% |
| Return on net worth | +13.2% | +14.1% | +17.6% | +12.5% | +13.6% | +4.0% | +7.7% |
| Debt / equity | 0.14 | 0.12 | 0.13 | 0.14 | 0.17 | 0.08 | 0.06 |
| Long-term debt / equity | 0.13 | 0.09 | 0.10 | 0.11 | 0.14 | 0.07 | 0.05 |
| Interest cover | 8.69 | 7.10 | 8.20 | 9.47 | 11.18 | 34.24 | 27.13 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 1.09 | 1.21 | 1.50 | 1.37 | 1.28 | 0.91 | 1.16 |
| Inventory turnover | 74.26 | 61.41 | 60.98 | 48.00 | 49.22 | 38.39 | 53.00 |
| Debtors turnover | 10.94 | 12.68 | 15.37 | 11.40 | 11.65 | 8.82 | 9.42 |
| EPS (₹) | 18.47 | 17.18 | 18.11 | 9.82 | 8.64 | 11.55 | 20.82 |
| Dividend per share (₹) | 0.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 149.34 | 130.22 | 113.11 | 92.80 | 68.70 | 292.65 | 281.74 |
To see the full year-wise statements and ratios of Global Health Limited, buy the company report.
Board of directors of Global Health Limited
Global Health has 10 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Naresh Trehan | Managing Director | 01 Jun 2007 | 19 Years 5 Months | Current |
| Praveen Mahajan Also directs: Global Health Patliputra Private Limited, Par Expert Tax Solutions LLP, J. K. Cement Limited. and 2 more | Director | 29 Oct 2020 | 6 Years 0 Months | Current |
| Rajan Bharti Mittal | Director | 28 Jul 2021 | 5 Years 3 Months | Current |
| Ravi Gupta Also directs: Devyani International Limited, Varun Beverages Limited, Epack Durable Limited and 5 more | Director | 28 Jul 2021 | 5 Years 3 Months | Current |
| Ravi Kant Jaipuria Also directs: Devyani International Limited, Varun Beverages Limited, Kiva Spirits and Company Limited and 3 more | Director | 09 Nov 2016 | 10 Years 0 Months | Current |
| Sunil Sachdeva | Director | 13 Aug 2004 | 22 Years 3 Months | Current |
Auditor
Global Health Limited is audited by WALKER CHANDIOK & CO.LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| WALKER CHANDIOK & CO.LLP | FY 2023 | 001076N/N500013 |
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 33.00%, foreign institutional investors hold 9.50%, domestic institutional investors hold 16.90% and retail and other public shareholders hold 40.60%.
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 33.00% | 33.00% | 33.00% | 33.00% |
| Public | 67.00% | 67.00% | 67.00% | 67.00% |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 14 Nov 2025 | 101194652 | Hdfc Bank Limited | ₹100 Cr | Open | |
| 29 Jul 2025 | 101137795 | Sbicap Trustee Company Limited | ₹50 Cr | Open | |
| 27 Mar 2025 | 101076570 | Others | ₹100 Cr | Open | |
| 25 Sep 2024 | 100981675 | Sbicap Trustee Company Limited | ₹400 Cr | Open | |
| 02 Aug 2021 | 100467917 | Yes Bank Limited | ₹140 Cr | Open |
To see the full charge records of Global Health Limited, buy the company report.
Total charge records: 14 View all charges
Deals & funding
Global Health Limited has 19 deals on record (7 funding rounds, 5 market trades, 5 secondary share transfers), with disclosed funding of ₹462.32 Cr; the latest was in June 2026.
Deals on record (5 of 19)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2024 | Market trade | ₹789.08 Cr | Buyer: Jm Financial Institutional Securities Limited, RJ Corp Limited Seller: Temasek, Jm Financial Institutional Securities Limited |
| Nov 2022 | IPO | ₹2,205.57 Cr | Investors: IPO Shareholders - Global Health Limited, Hdfc Small Cap Fund, Ontario Teachers Pension Plan Board-NP3A-All Seller: The Carlyle Group, an individual |
| Mar 2018 | Funding round | ₹20 Cr | Investors: RJ Corp Limited , Agio Image Limited, 2 individuals |
| Jan 2015 | Secondary share transfer | Undisclosed | Buyer: Temasek Seller: Punj-Lloyd Limited |
| Jun 2012 | Funding round | ₹69.79 Cr | Investors: Punj-Lloyd Limited , an individual |
To see the full deal history of Global Health Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Global Health Limited has 66 court cases on record: 14 filed by Global Health, 53 filed against it. 16 cases are pending and 50 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 38 | 34 | 9 |
| High courts | 21 | 14 | 5 |
| Supreme Court | 6 | 5 | 2 |
| NCLT | 1 | 0 | 0 |
Cases on record (5 of 66)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South East, Delhi | Commercial suit | Filed against the company by GDX Security Solutions India Private Limited | Pending |
| High Court, DELHI | Writ petition | Filed against the company by Ms Global Health Limited Through Mr Rajeev Khanna and 1 other | Pending |
| High Court, DELHI | Writ petition | Filed by the company against Ms Global Health Limited Through Mr Rajeev Khanna and 4 others | Pending |
| District court, Faridabad, Haryana | Court case (COMI) | Filed against the company | Pending |
| District court, Gautam Buddha Nagar, Uttar Pradesh | Criminal case | Filed against the company by State of U.P. | Pending |
To see the full case history of Global Health Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Global Health Limited was last rated by Crisil on 22 May 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 22 May 2020 |
To see the full credit ratings and regulatory alerts of Global Health Limited, buy the company report.
MSME payment delays
Global Health Limited has 39 MSME Form 1 returns on record between 2013 and 2024, listing 34,957 overdue payments to 652 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 652)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Midmark (India) Private Limited | |||
| an individual supplier | |||
| an individual supplier | |||
| Microjob Solution Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Global Health Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Global Health has 3 subsidiary companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Medanta Holdings Private Limited | U74140DL2013PTC250579 | |
| Global Health Patliputra Private Limited | U74999DL2015PTC283932 | |
| GHL Pharma & Diagnostic Private Limited | U85110DL2022PTC400942 |
To see the full group structure of Global Health Limited, buy the company report.
Employees & EPFO
Global Health Limited has a workforce of 10,344 employees on its EPFO records as of May 2026, across 6 active EPFO establishments.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 10,344 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Global Health Limited, buy the company report.
GST
Global Health has 11 GST registrations: 8 active and 3 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCG2681C2ZW | Delhi | Active | 01 Jul 2017 |
| 06AACCG2681C1ZZ | Haryana | Active | 01 Jul 2017 |
| 09AACCG2681C1ZT | Uttar Pradesh | Active | 01 Jul 2017 |
| 10AACCG2681C1ZA | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Global Health Limited, buy the company report.
Recent activity
Global Health Limited has 18 board changes on record since 2004: 14 appointments and 4 cessations. The latest: Shonan Purie Trehan was appointed as Director on 13 Mar 2026.
37 earlier events are in the company report.
News
Frequently asked questions
Global Health is an active public limited company based in New Delhi, Delhi, India. The company works in hospitals, within the healthcare industry. It was incorporated on 13 August 2004 (22+ years old) and is registered under CIN L85110DL2004PLC128319. Listed on BSE: 543654 and NSE: MEDANTA.
Global Health reported revenue of ₹4,410.27 Cr for FY 2025-26 (up 19.4% YoY) based on consolidated financials.
Global Health has 10 current directors:
- Naresh Trehan - Managing Director
- Pankaj Prakash Sahni - Whole-Time Director
- Praveen Mahajan - Director
- Rajan Bharti Mittal - Director
- Ravi Gupta - Director
- Ravi Kant Jaipuria - Director
- Sunil Sachdeva - Director
- Hari Shanker Bhartia - Director
- Vikram Singh Mehta - Director
- Shonan Purie Trehan - Director
The latest financial statements of Global Health on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 19 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Global Health is 07AACCG2681C2ZW, registered in Delhi. The company has 11 GST registrations in all, of which 8 are active and 3 are cancelled or inactive. Other active GSTINs include 06AACCG2681C1ZZ (Haryana), 09AACCG2681C1ZT (Uttar Pradesh), 10AACCG2681C1ZA (Bihar).
The CIN (Corporate Identification Number) of Global Health is L85110DL2004PLC128319. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Global Health is a listed company as per MCA records. Its shares are listed on both BSE (code: 543654) and NSE (symbol: MEDANTA).
Global Health has 66 court cases on record: 14 filed by the company and 53 filed against it. 16 are pending. Most are in the district courts.
Global Health was incorporated on 13 August 2004, making it 22+ years old. It is registered with the Registrar of Companies, Delhi.
Global Health has 19 deals on record (7 funding rounds, 5 market trades, 5 secondary share transfers), with disclosed funding of ₹462.32 Cr; the latest was in June 2026.
Shonan Purie Trehan was appointed as Director on 13 Mar 2026. Ratnasami Venkatesh ceased to be Nominee Director on 14 Nov 2024. Yogesh Kumar Gupta was appointed as CFO on 26 Feb 2024. Global Health has 18 board changes on record in total.

